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Nitrogen-substituted methylenecyclopropanes have been prepared by a strain-driven 
Overman rearrangement of cyclopropenylmethyl trichloroacetimidates. The reaction 
proceeds at room temperature and without the need of a transition-metal catalyst. 
Furthermore, it has been shown that C-3 substituted cyclopropenylmethyl 




 Methylenecyclopropanes are strained, but remarkably stable, unsaturated 
carbocycles that have attracted significant interest for their strain-driven reactivity.[1-
4] Typically, these highly strained systems are susceptible to ring-opening reactions 
[5-17], cycloaddition reactions [18-23] and ring-expansion reactions [23-28]. They 
have also proved to be precursors for densely functionalized cyclopropanes via ring-
retaining C-C [29-37] and C-heteroatom bond forming reactions to their exocyclic 
double bond. [38-40]  
 A range of methods for the synthesis of methylenecyclopropanes exist 
[4],[41], however, relatively few of these consider the synthesis of heteroatom-
substituted structures. Cyclopropenes, bearing an allylic leaving group, can be 
transformed into methylenecyclopropanes upon nucleophilic attack to the 
cyclopropene double bond. Such a process is thermodynamically favored due to the 
relief of strain energy associated with movement of the double bond to the exocyclic 
position. This approach has been developed for the synthesis of carbon/hydrogen-
substituted methylenecyclopropanes [42-47], but is also one of the limited ways to 
prepare heteroatom-substituted systems. One notable example is the strain-driven 
[3,3]-sigmatropic rearrangement of cyclopropenylmethyl esters to acetoxy-substituted 
methylenecyclopropanes by Marek and co-workers (eq 1, Scheme 1) [43]. The groups 
of Marek [43] and Rubin [47] also reported a [2,3]-sigmatropic rearrangement of 
cyclopropenes to provide methylenecyclopropylphosphine oxides (eq 2 and 3, 
Scheme 1). Such heteroatom-substituted systems are of interest as phosphorous, 
oxygen and nitrogen substituents are ubiquitous in bioactive small molecules. In 
particular, N-substituted methylenecyclopropanes may act as precursors to 
cyclopropylamines and cyclopropylureas, which are found in a range of bioactive 
molecules. For example,  
 
Scheme 1. Previous syntheses of heteroatom-substituted methylenecylopropanes 





cyclopropylurea I displays anti-HIV activity[48], II is a kinase inhibitor[49] and 
phenylcyclopropylamine III is a mono-amine oxidase (MAO) inhibitor (Figure 
1).[50] As there are no general methods for the synthesis of nitrogen substituted 
methylenecyclopropanes there is a need for methodology to allow their preparation. 
To address this gap, we hypothesized that an allylic trichloroacetimidate 
rearrangement (Overman rearrangement) of cyclopropenylmethyl 
trichloroacetimidates (eq 4) should afford 2,2,2-trichloro-N-(2-
methylenecyclopropyl)acetamides.  
 The Overman rearrangement is a powerful method for converting allylic 
alcohols to allylic amines. Typically, allylic trichloroacetimidates undergo either 
thermal or Pd(II)-catalyzed rearrangement to allylic trichloroacetamides that may be 
subsequently transformed into allylic amines by hydrolysis. [51-52] The thermal 
conditions typically require xylenes at reflux, however, we hypothesized that the 
strain relief associated with a cyclopropenylmethyl trichloroacetimidate undergoing 
rearrangement to a 2,2,2-trichloro-N-(2-methylenecyclopropyl)acetamide would allow 
the reaction to occur without a catalyst and without the need for high temperatures.  
Herein, we report the successful catalyst-free rearrangement of these systems at 
ambient temperature.  
 
 
Figure 1. Representative bioactive N-substituted cyclopropanes. 
 
Initial optimization of both imidate synthesis and subsequent Overman 
rearrangement utilized p-bromobenzaldehyde-derived cyclopropenylcarbinol 1a, 
(Table 1).  The optimum conditions for trichloroacetimidate synthesis involved 
treating alcohol 1a with a catalytic amount of DBU in CH2Cl2 at -78 
oC, followed by 
addition of trichloroacetonitrile and warming to -15 oC. The imidate 2a could be 
identified in the 1H NMR spectrum by the shift of the singlet corresponding to the 
proton adjacent to oxygen from 5.63 ppm in 1a downfield to 6.76 ppm for the imidate 
2a. The use of other bases such as NaH and KH gave only recovered starting material. 
It was found to be important that the imidation reaction with DBU should be left for 
no longer than 3 hours and allowed to warm to a maximum of -15 oC. Longer reaction 
time, or higher temperatures led to decomposition and/or lower yielding partial 
rearrangement to the amide. The imidate could be obtained after rapid removal of all 
volatile components under reduced pressure and was used directly without further 
purification.  
 
Table 1. Optimization of the Overman rearrangement of 2a to yield 
trichloroacetimidate 3a.  
 
Entry additive conditions Time Yield[a] 
1 none 30 oC, CH2Cl2 40 h 21% 
2 1 equiv K2CO3  30 
oC, CH2Cl2 40 h 63% 
3 5 mol% 
PdCl2(MeCN)2  
30 oC, CH2Cl2  24 h <5%  
4 1 equiv K2CO3 30 
oC, DMF 22 h 53% 
[a] isolated yields. 
 
With conditions for the preparation of the imidate in hand, attention was 
turned towards identifying optimum conditions for the Overman rearrangement. We 
were delighted to find that imidate 2a underwent efficient [3,3]-sigmatropic 
rearrangement under mild conditions (30 oC, CH2Cl2, Table 1, entry 1) to yield a 
single isomer of 3a. This two-step yield was significantly increased by the addition of 
K2CO3 as a base. However, changing the solvent to DMF resulted in a faster but 
lower yielding reaction (entry 4, full conversion in 22 hours). It also quickly became 
apparent that catalysis of the rearrangement by PdCl2(MeCN)2 was inefficient in 
comparison to the mild thermal conditions (entry 3, Table 1). The Pd-catalyst gave 
only trace product accompanied by significant decomposition. Evidence for 
methylenecyclopropane formation was indicated by 1H NMR resonance of the proton 
adjacent to the oxygen of the imidate shifting from a singlet at 6.76 ppm to a triplet at 
7.13 ppm corresponding to the alkene. 
 A range of different aryl-substituted cyclopropenylmethyl 
trichloroacetimidates was subjected to rearrangement (Table 2). It can be observed 
that derivatives with electron-rich (3d-e) and heterocyclic (3b) aryl groups underwent 
efficient rearrangement. Halogen-substituted phenyl groups were well tolerated (3a 
and 3g), as was ortho-substitution (3g). Highly electron-deficient aryl nitro-
substituted systems however, did not undergo rearrangement at all and just provided 
recovered starting material. This lack of reactivity is likely due to the electron-
deficient aryl groups disfavoring the development of positive charge in the transition 
state at the oxygen-bearing carbon. This observation, coupled with the higher 
reactivity of electron-rich aryl groups, suggest the possibility of a transition state with 
ionic character. Curiously, the dodecyl aldehyde-derived cyclopropenylcarbinol 1j 
could not be converted to the corresponding imidate despite extended reaction times 
and excesses of reagents [53]. 
 
Table 2. Scope of the Overman rearrangement to yield 2,2,2-trichloro-N-(2-







   
 
 
[a] Isolated yields over two steps, representing a single E-isomer of the product. [b] 
Imidate was formed but rearrangement did not proceed. [c] Imidate could not be 
formed. 
 
All of the methylenecyclopropanamides were obtained as a single E-isomer, 
suggesting that the reaction likely proceeds through a [3,3] sigmatropic rearrangement 
mechanism as is normally observed for the Overman rearrangement.[52] The 
stereochemistry of the rearrangement is assigned based on nOe correlations and is 
explained by a pseudo chair conformation 4 similar to that proposed by Marek and 
co-workers.[43]  
 
Scheme 1. Manipulation of methylenecyclopropane 3a/f under basic conditions 
to yield ureas 5a/f or oxaacetamide 6. 
 
 
 Attempts to reduce or hydrolyze the trichloroacetamides to reveal the free 
amines were not successful. Conditions investigation included: acid hydrolysis (1M 
HCl, 0oC), basic hydrolysis (KOH/EtOH) and reductive cleavage (DIBAL-H or 
NaBH4); in each case recovery of starting material along with decomposition was 
observed. This was attributed to an unstable isocyanate intermediate resulting in the 
loss of chloroform, as shown by Nishikawa et al.[54] A different course of action was 
taken, which was to generate the isocyanate intermediate from 3a/3f at -78 oC with 
Cs2CO3 in DMF before capturing it with pyrrolidine to successfully yield the desired 
ureas 5a/5f respectively. Cyclopropylureas are valuable targets given their occurrence 
in a range of bioactive molecules, including: kinase inhibitors [49], epoxide hydrolase 
inhibitors [55] and HIV-1 reverse transcriptase inhibitors [48]. Interestingly when 
bench grade DMF, which contained traces of water, was used a 2-oxaacetamide 6 can 
be formed in a moderate yield.[56]  
Given the potential of methylenecyclopropanes 3 as precursors to nitrogen-
substituted cyclopropanes, a catalytic hydrogenation was also attempted in order to 
provide the saturated system. Hydrogenation initially yielded a mixture of reduction 
products identified as various dehalogenated cyclopropanes. Fortuitously, with 
extended reaction times, hydrogenation yielded the monochloro amide 7 as a 2.5:1 
mixture of diastereoisomers in 41% yield. Of note is the remaining chloride in 7, 
representing a useful handle for further functionalization by substitution or coupling 
chemistry. 
 
Scheme 2. Catalytic hydrogenation of methylenecyclopropane 3f to yield 




 We also briefly investigated the Overman rearrangement of 
cyclopropenylmethyl trichloroacetimidate 9 bearing a gem-dimethyl group at C-3. 
While the trichloroacetimidates 9 could be readily prepared, they underwent rapid 
hydrolytic ring-opening in the presence of silica-gel to form allenylcarbinol 10. This 
reaction pathway is highly favored due to the stabilization of the allenyl cation by the 
gem-dimethyl group in conjunction with the relief of ring-strain. Indeed, we have 
previously demonstrated that related cyclopropenylmethyl acetates undergo ring-
opening to allenyl cations 11 in the presence of TiCl4.[57] 
 
Scheme 3. Formation of allenylcarbinols 10 by silica gel-induced hydrolytic ring-





 In summary, we have developed a method for the preparation of 
functionalized nitrogen-substituted methylenecyclopropanes via an Overman 
rearrangement. There are currently no general methods available for these structures, 
which as we have shown have some potential as precursors to cyclopropylureas. 
These rearrangements occur under very mild conditions by virtue of strain-relief and 
also occur with complete stereoselectivity to give the E-methylenecyclopropanes. We 
have also described initial studies on the manipulation of these systems and divergent 
reactivity towards the formation of allenyl carbinols when cation-stabilizing groups 




Unless otherwise stated all reactions were carried out under an argon or nitrogen 
atmosphere in dry glassware. Reactions were monitored by TLC using glass-backed 
silica gel plates or by GC and GC/MS Compounds were purified using flash column 
chromatography or by radial chromatography with a Chromatotron®. Reaction 
solvents were obtained from a solvent purification system having passed through 
anhydrous alumina columns. nBuLi was titrated against diphenylacetic acid prior to 
use. 1,2,2-Tribromo-1-methylpropane [58], 1,1,2-tribromo-2,3,3-
trimethylcyclopropane [59], (2-methylcycloprop-1-enyl)(4-bromophenyl)methanol 1a 
[54], phenyl(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 1c [60], (2-
methylcycloprop-1-enyl)(4-methoxyphenyl)methanol 1d [58], 2-methylcycloprop-1-
enyl)(4-methylphenyl)methanol 1e [58], phenyl(2,3,3-trimethylcycloprop-1-
enyl)methanol 8a [59], and (4-bromophenyl)(2,3,3-trimethylcycloprop-1-
enyl)methanol 8b [59] were synthesized and characterized as previously reported. 
Other reagents were commercially available and used without further purification. 
The following abbreviations were used to describe 1H spectra peak splitting patterns; 
s = singlet, d = doublet, dd = doublet of doublets, ddd = doublet of doublet of 
doublets, dddd = doublet of doublet of doublet of doublets, t = triplet, dt = doublet of 
triplets, q = quartets, dq = doublet of quartets, bs = broad singlet, m = multiplet and ad 
= apparent doublet. IR spectra were recorded as films on NaCl plates (liquids) or in a 




General procedure of the synthesis- of cyclopropenylcarbinols. 
In an oven dried 2-neck flask was added 1,2,2-tribromo-1-methylpropane (1.0 equiv.) 
and anhydrous Et2O (20 mL) before cooling to -78 
oC and adding n-BuLi (1.45 M, 1.9 
equiv.). The resultant solution was warmed to -10oC for 30 min before cooling to -
50oC and adding the selected aldehyde. The solution was taken to room temperature 
after 10 min and left to stir for 2 h before quenching with H2O (20 mL). The mixture 
was then extracted with Et2O (3 x 20 mL), dried on Na2SO4 and filtered before the 
solvent was removed under reduced pressure. The crude oil was the purified by means 
of flash chromatography on silica gel treated with Et3N (typically ethyl 
acetate:hexanes). 
 
(2-Methylcycloprop-1-enyl)[1-(p-toluenesulfonyl)pyrrol-2-yl]methanol (1b). From N-
toluenesulfonylpyrrole-2-carboxaldehyde as a yellow oil using 100% CH2Cl2 for 
purification; 179.5 mg, 29% yield. IR (ATR): 3534, 2948, 2869, 1596, 1362, 1173 
cm-1. 1H NMR (300 MHz, CDCl3): δ 0.99 (d, J = 8.4 Hz, 1H), 1.05 (d, J = 8.4 Hz, 
1H), 2.09 (d, J = 1.5 Hz, 3H), 2.40 (s, 3H), 2.94 (d, J = 6 Hz, 1H), 5.99 (s, 1H), 6.22-
6.25 (m, 2H), 7.26-7.30 (m, 3H), 7.73 (d, J = 8.4 Hz, 2H). 13C NMR (75 MHz, 
CDCl3): δ 9.9, 11.5, 21.7, 62.8, 109.1, 110.8, 111.7, 114.3, 123.8, 126.9, 130.0, 134.9, 
136.2, 145.2. HRMS (+EI-Orbitrap): m/z for C16H17NO3SNa calcd 326.0826; found, 
326.0821. 
 
1-(2-Methylcycloprop-1-enyl)dodecan-1-ol (1j) From dodecylaldehyde as a colorless 
oil using 20% ethyl acetate: hexanes; 345 mg, 57%. 1H NMR (400 MHz, CDCl3) δ 
0.89 (t, J = 7.0 Hz, 3H), 0.92 (d, J(ab) = 9.0 Hz, 1H), 0.95 (d, J(ab) = 9.0 Hz, 1H), 1.19 
– 1.47 (m, 18H), 1.70 (dd, J = 7.0, 15.0 Hz, 2H), 1.87 (br s, 1H), 2.10 (d, J = 1.5 Hz, 
3H), 4.60 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 8.2, 11.5, 14.1, 22.7, 25.2, 29.3, 
29.5, 29.6, 29.6, 29.6, 31.9, 35.8, 68.0, 108.3, 111.2. IR: 3416 cm-1. HRMS (MMI-
TOF) (m/z): (M - H)+ calcd for C16H29O, 237.2213; found, 237.2214. 
 
(2-Methylcycloprop-1-enyl)(3-methoxyphenyl)methanol (1f). From 3-
methoxybenzaldehyde as pale yellow oil using 20% ethyl acetate: hexanes; 45.5 mg, 
20% yield. IR (ATR): 3403, 2943, 2869, 1260 cm-1. 1H NMR (300 MHz, CDCl3): δ 
1.02 (d, J = 8.4 Hz, 1H), 1.06 (d, J = 8.4 Hz, 1H), 2.09 (d, J = 1.2 Hz, 3H), 3.80 (s, 
3H), 5.64 (bs, 1H), 6.82-6.86 (m, 1H), 6.96-6.99 (m, 2H), 7.27 (t, J = 8.1 Hz, 1H). 13C 
NMR (75 MHz, CDCl3): δ 20.0, 20.9, 55.3, 112.6, 113.5, 119.9, 121.1, 128.3, 129.7, 
138.1, 159.8, 162.3. HRMS (+EI-Orbitrap): m/z for C12H15O2 calcd 191.1072; found, 
191.1067. 
 
(2-Methylcycloprop-1-enyl)(2-chlorophenyl)methanol (1g). From 2-
chlorobenzaldehyde as a clear oil using 20% ethyl acetate: hexanes; 184.8 mg >99% 
yield. IR (ATR): 3357, 2964, 2871, 1441 cm-1. 1H NMR (300 MHz, CDCl3): δ 1.03 
(s, 2H), 2.06 (s, 3H), 2.59 (bs, 1H), 6.03 (bs, 1H), 7.22-7.28 (m, 2H), 7.30-7.37 (m, 
1H), 7.50-7.53 (m, 1H). 13C NMR (75 MHz, CDCl3): δ 9.1, 11.4, 67.2, 109.7, 110.6, 
127.1, 127.9, 128.9, 129.6, 132.3, 138.7. HRMS (+EI-Orbitrap): m/z for C11H12ClO 
calcd 195.0571; found, 195.0569. 
 
2-Methylcycloprop-1-enyl)(4-nitrophenyl)methanol (1h). From 4-nitrobenzaldehyde 
as a yellow semi-solid using 50% Et2O:pentane; 335.1 mg, 94% yield. IR (ATR): 
3594, 3054, 2986, 1268 cm-1. 1H NMR (400 MHz, CDCl3) δ 1.05 (d, J(ab) = 8.3 Hz, 
1H), 1.08 (d, J(ab) = 8.3 Hz, 1H), 2.11 (d, J = 1.4 Hz, 3H), 5.80 (s, 1H), 7.61 (d, J = 
8.9 Hz, 2H), 8.24 (d, J = 8.9 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 9.1, 11.4, 69.2, 
110.0, 111.6, 123.8, 127.0, 148.4. HRMS (MMI-TOF): m/z for (2M + NH4)
+ calcd for 
C22H26N3O6, 428.1822; found: 428.1828. 
 
(2-Methylcycloprop-1-enyl)(3-nitrophenyl)methanol (1i). From 3-nitrobenzaldehyde 
as an off-white semi-solid without need for purification by column; 309.2 mg, 88% 
yield. IR (ATR): 3583, 2857, 1529, 1350 cm-1. 1H NMR (300 MHz, CDCl3): δ 1.04 
(d, J = 8.3 Hz, 1H), 1.08 (d, J = 8.3 Hz, 1H), 2.11 (d, J = 1.4 Hz, 3H), 5.79 (s, 1H), 
7.55 (t, J = 7.9 Hz, 1H), 7.81 – 7.72 (m, 1H), 8.14 - 8.18 (m, 1H), 8.29 – 8.31 (m, 
1H). 13C NMR (75 MHz, CDCl3): δ 9.1, 11.4, 69.1, 109.9, 111.5, 121.4, 122.8, 129.5, 
132.5, 143.4, 189.9. HRMS (+EI-Orbitrap): m/z for C11H11NO3Na calcd 228.0636; 
found, 228.0631.  
 
(2-Fluorophenyl)(2,3,3-trimethylcycloprop-1-en-1-yl)methanol (8c). 
From 2-fluorobenzaldehyde as a clear oil using 20% ethyl acetate: hexanes for 
purification; 610.5 mg, 20% yield. IR (ATR): 3447, 2957, 1610, 1487, 1454, 1032, 
1032, 754 cm-1. 1H NMR (300 MHz, CDCl3): δ 1.03 (s, 3H), 2.10 (3, 3H), 1.63 (bs, 
1H), 1.97 (s, 3H), 5.93 (s, 1H), 7.03 (app t, J = 8.7 Hz, 1H), 7.12 (t, J = 7.2 Hz, 1H), 
7.26-7.28 (m, 1H), 7.47 (t, J = 7.2 Hz). 13C NMR (75 MHz, CDCl3): δ 8.6, 22.2, 25.3, 
25.6, 65.1 (d, J = 4.6 Hz), 115.3 (d, J = 21.8 Hz), 124.6 (d, J = 13.8 Hz), 124.9 (d, J = 
3.5 Hz), 128.5 (d, J = 4.6 Hz), 129.9 (d, J = 8.1 Hz), 159.9 (d, J = 245.1 Hz). HRMS 
(ASAP-TOF): m/z For C13H15FO +H – H2O calcd 189.1080; found, 189.1071. 
 
General procedure for the synthesis of nitrogen-substituted 
alkylidenecyclopropanes. 
To a stirred solution of cyclopropenylcarbinol (1 equiv.) in CH2Cl2 (~0.1 M), was 
added DBU (0.15 equiv.) followed by trichloroacetonitrile (1.5 equiv.) at -78 oC. The 
resulting solution was allowed to warm to -10 oC over a period of 2 h before the 
reaction mixture was evaporated to dryness under reduced pressure. The resulting oil 
was in most cases identified as the intermediate imidate by NMR of the crude reaction 
mixture and was used directly in the rearrangement step. Where the 1H NMR of the 
crude imidate was clean a listing of the signals is provided below. A solution of crude 
imidate (1 equiv.) and K2CO3 (1.5 equiv.) in CH2Cl2 (1 mL) was allowed to stir at 30 
oC for 40 h. After this time the solution was filtered before removal of solvent by 
evaporation under reduced pressure. The crude semisolid was purified by means of 
flash chromatography on a neutral alumina column (ethyl acetate/hexanes) to yield 
the exocyclic cyclopropenyl trichloroacetamide. 
 
1-[(E)-2-(4-Bromophenyl)methylidene-1-methylcyclopropylamino]-2,2,2-trichloro-1-
ethanone (3a). From 1a as an off-white semi-solid after purification with 20% ethyl 
acetate: hexanes; 51 mg, 63% yield over two steps. Imidate: 1H NMR (300 MHz, 
CDCl3): δ 1.06 (d, J = 8.3 Hz, 1H), 1.14 (d, J = 8.3 Hz, 1H), 2.09 (d, J = 1.5 Hz, 3H), 
6.76 (s, 1H), 7.34 (d, J = 8.3 Hz, 2H), 7.51 (d, J = 8.5 Hz, 2H), 8.43 (s, 1H). 3a: IR 
(ATR): 3289, 2922, 2850, 1694, 1506 cm-1. 1H NMR (300 MHz, CDCl3): δ 1.60 (s, 
3H), 1.76 (dd, J = 10.9, 2.6 Hz, 1H), 1.83 (dd, J = 10.9, 2.6 Hz, 1H), 7.07 (s, 1H), 
7.13 (t, J = 2.6 Hz, 1H), 7.39 (d, J = 8.5 Hz, 2H), 7.46 (d, J = 8.6 Hz, 2H). 13C NMR 
(75 MHz, CDCl3): δ 19.9, 20.9, 29.9, 120.3, 121.8, 128.7, 128.8, 131.8, 135.6, 162.3. 
HRMS (+EI-Orbitrap): m/z for C13H11BrCl3NONa calcd 403.8987; found, 403.8982. 
 
1-[(E)-2-{[1-(p-Tolylsulfonyl)-1H-pyrrol-2-yl]methylidene}-1-
methylcyclopropylamino]-2,2,2-trichloro-1-ethanone (3b). From 1b as a yellow oil 
after purification with 100% CH2Cl2; 275 mg, >99% yield over two steps. IR (ATR): 
3364, 2969, 2027, 1713, 1494, 1367, 1174 cm-1. 1H NMR (300 MHz, CDCl3): δ 1.55 
(s, 3H), 1.55-1.59 (m, 1H), 1.62 (dd, J = 11.1, 2.7 Hz, 1H), 2.36 (s, 3H), 6.27 (t, J = 
3.9 Hz, 1H), 6.52-6.52 (m, 1H), 6.99 (s, 1H), 7.26 (d, J = 8.1 Hz, 2H), 7.34 (dd, J = 
4.8, 1.5 Hz, 1H), 7.64 (t, J = 2.7 Hz, 1H), 7.72 (d, J = 8.1 Hz, 2H). 13C NMR (75 
MHz, CHCl3): δ 19.6, 21.0, 21.7, 31.4, 110.5, 112.5, 112.7, 123.1, 127.1, 128.5, 
130.1, 131.9, 135.9, 145.1, 161.98. HRMS (+EI-Orbitrap): m/z for C18H17Cl3N2O3S 
+H calcd 447.0103; found, 447.0098. 
 
1-[(E)-2-Phenylmethylidene-1-methylcyclopropylamino]-2,2,2-trichloro-1-ethanone 
(3c). From 1c as an off-white semisolid after purification with 20% ethyl acetate: 
hexanes; 80.1 mg, 83% yield over two steps. Imidate: 1H NMR (300 MHz, CDCl3): δ 
1.07 (d, J = 8.4 Hz, 1H), 1.15 (d, J = 8.4 Hz, 1H), 2.09 (d, J = 1.4 Hz, 3H), 6.82 (s, 
1H), 7.32-7.40 (m, 3H), 7.45-7.48 (m, 2H), 8.42 (s, 1H). 1c: IR (ATR): 3415, 3054, 
2986, 1719, 1492, 1421, 1265, 895cm-1. 1H NMR (300 MHz, CDCl3): δ 1.61 (s, 3H), 
1.80 (dd, J = 10.8, 2.6 Hz, 1H), 1.86 (dd, J = 10.8, 2.6 Hz, 1H), 7.06 (bs, 1H), 7.19 (t, 
J = 2.6 Hz, 1H), 7.27-7.38 (m, 3H), 7.45-7.56 (m, 2H). 13C NMR (75 MHz, CDCl3): δ 
20.0, 21.0, 29.9, 121.2, 127.2, 127.9, 128.0, 128.7, 136.6, 162.3. HRMS (MMI-TOF) 
m/z: (M + H)+ calcd for C13H13NOCl3: 304.0064; found: 304.0057. 
 
1-[(E)-2-(4-Methoxyphenyl)methylidene-1-methylcyclopropylamino]-2,2,2-trichloro-
1-ethanone (3d). From 1d as an off-white semi-solid after purification with 30% ethyl 
acetate: hexanes; 145.6 mg, 77% yield over two steps. Imidate: 1H NMR (300 MHz, 
CDCl3): δ 1.09 (dd, J = 23.7, 8.4 Hz, 2H), 2.09 (d, J = 1.5 Hz, 3H), 3.79 (s, 3H), 6.75 
(s, 1H), 6.85-6.92 (m, 2H), 7.38 (d, J = 8.7, 2H), 8.38 (s, 1H). 3d: IR (ATR): 3423, 
3054, 2986, 1717, 1512, 1421, 1265, 705 cm-1. 1H NMR (300 MHz, CDCl3): δ 1.60 
(s, 3H), 1.75 (dd, J = 8.6, 2.4 Hz, 1H), 1.81 (dd, J = 10.7, 2.8 Hz, 1H), 3.81 (s, 3H), 
6.89 (d, J = 8.8 Hz, 2H), 7.12 (t, J = 2.6 Hz, 1H), 7.48 (d, J = 8.7 Hz, 2H). 13C NMR 
(75 MHz, CHCl3): δ 19.8, 21.0, 29.9, 55.3, 114.1, 120.5, 125.5, 128.4, 129.4, 159.4, 




ethanone (3e). From 1e as an off white semisolid after purification with 30% 
ethylacetate: hexanes; 281 mg, 98% yield over two steps. Imidate: 1H NMR (300 
MHz, CDCl3): δ 1.06 (d, J = 8.4 Hz, 1H), 1.14 (d, J = 8.4 Hz, 1H), 2.10 (d, J = 1.5 
Hz, 3H), 2.36 (s, 3H), 6.78 (s, 1H), 7.19 (d, J = 7.9 Hz, 2H), 7.35 (d, J = 7.9 Hz, 2H), 
8.39 (s, 1H). 3e: IR (cm-1): 3417, 3050, 3030, 2971, 2929, 2864, 1715, 1513, 1489, 
1236, 821, 711. 1H NMR (300 MHz, CDCl3): δ 1.60 (s, 3H), 1.77 (dd, J = 10.6, 2.6 
Hz, 1H), 1.83 (dd, J = 10.7, 2.6 Hz, 1H), 2.35 (s, 3H), 7.01 (bs, 1H), 7.11-7.19 (m, 
3H), 7.44 (d, J = 8.1 Hz, 2H). 13C NMR (75 MHz, CDCl3): δ 20.1, 23.1, 21.5, 30.0, 
121.1, 126.9, 127.2, 129.5, 134.0, 138.0, 162.4. HRMS (MMI-TOF) m/z: (M + H)+ 
calcd for C14H15NOCl3: 318.0221; found: 318.0214. 
 
1-[(E)-2-(3-Methoxyphenyl)methylidene-1-methylcyclopropylamino]-2,2,2-trichloro-
1-ethanone (3f). From 1f an off white semisolid after purification with 30% ethyl 
acetate: hexanes; 38 mg, 47% yield over two steps. 3f: IR (cm-1): 3443, 2957, 1600, 
1511, 1249, 1170, 1030. 1H NMR (300 MHz, CDCl3): δ 1.60 (s, 3H), 1.79 (dd, J = 
10.9, 2.6 Hz, 1H), 1.86 (dd, J = 10.9, 2.6 Hz, 1H), 3.82 (s, 3H), 6.81-6.86 (m, 1H), 
7.06 (s, 1H), 7.09 (t, J = 2.4 Hz, 1H), 7.12 (ap, 1H), 7.15-7.16 (m, 1H), 7.27 (t, J = 7.8 
Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 20.0, 20.9, 29.9, 55.3, 92.6, 112.6, 113.5, 
119.9, 121.1, 128.3, 129.7, 138.1, 159.8, 162.3. MS: m/z 356 (M+Na, 100), 213 (17). 
HRMS (+EI-Orbitrap): m/z for C14H14Cl3NO2Na calcd 355.9987; found, 355.9982. 
 
1-[(E)-2-(2-Chlorophenyl)methylidene-1-methylcyclopropylamino]-2,2,2-trichloro-1-
ethanone (3g). From 1g as an off-white semisolid after purification with 20% ethyl 
acetate: hexanes; 88.8 mg, 48% yield over two steps. Imidate: 1H NMR (300 MHz, 
CDCl3): δ 1.08 (d, J = 8.4 Hz, 1H), 1.26 (d, J = 8.4 Hz, 1H), 2.08 (d, J = 1.5 Hz, 3H), 
7.15 (s, 1H), 7.25-7.32 (m, 2H), 7.38-7.41 (m, 1H), 7.53-7.56 (m, 2H), 8.46 (s, 1H). 
3g: IR (ATR): 3317, 2968, 1695, 1495 cm-1. 1H NMR (300 MHz, CDCl3): δ 1.62 (s, 
3H), 1.81 (dd, J = 11.1, 2.6 Hz, 1H), 1.88 (dd, J = 11.1, 2.6 Hz, 1H), 7.10 (bs, 1H), 
7.18-7.25 (m, 2H), 7.38 (dd, J = 7.7, 1.6 Hz, 1H), 7.58 (t, J = 2.6 Hz, 1H), 7.79 (dd, J 
= 7.6, 1.8 Hz, 1H). 13C NMR (75 MHz, CHCl3): δ 20.1, 20.9, 30.0, 117.1, 126.8, 
127.2, 129.0, 129.9, 130.7, 133.6, 134.2, 162.2. HRMS (+EI-Orbitrap): m/z for 
C13H11Cl4NONa calcd 359.9492; found, 359.9487. 
 
1-{(E)-2-[(4-Bromophenyl)methylidene]-1-methylcyclopropylamino}(1-
pyrrolidinyl)formaldehyde (5a). To a solution of 3a (62 mg, 0.16 mmol) in anhydrous 
DMF (2 mL) under nitrogen was added Cs2CO3 (140 mg, 0.43 mmol) at -78 
oC. The 
mixture was allowed to stir for 1 h before the slow addition of pyrrolidine (140 μL, 
120 mg, 1.69 mmol), which was subsequently allowed to warm to room temperature 
over 18 h. After this time the mixture was diluted with 50% ethyl acetate in hexanes 
and washed with water. The crude mixture was dried on Na2SO4, filtered and had the 
solvent removed under reduced pressure. The crude oil was purified by means of flash 
chromatography with 100% ethyl acetate to afford 5a as a yellow oil in a 39% yield 
(21.0 mg, 0.06 mmol). IR (ATR): 3252, 2970, 1689, 1489, 1383, 1161 cm-1. 1H NMR 
(400 MHz, CDCl3): δ 1.56 (s, 3H), 1.74-1.77 (m, 4H), 2.02 (s, 3H), 2.41-2.47 (m, 
2H), 2.68-2.72 (m, 2H), 6.65 (bs, 1H), 7.33 (d, J = 8.4 Hz, 2H), 7.53 (d, J = 8.4 Hz, 
2H). 13C NMR (100 MHz, CDCl3): δ 11.8, 23.9, 24.5, 46.2, 77.9, 122.1, 129.7, 130.3, 
131.0, 131.5, 158.5, 171.7. HRMS (+EI-Orbitrap): m/z For C16H19BrN2O +H calcd 
335.0759; found, 335.0754. 
 
1-{(E)-2-[(3-Methoxyphenyl)methylidene]-1-methylcyclopropylamino}(1-
pyrrolidinyl)formaldehyde (5f). To a solution of 3f (88.1 mg, 0.26 mmol) in 
anhydrous DMF (2 mL) under nitrogen was added Cs2CO3 (214.5 mg, 0.75 mmol) at 
-78 oC. The mixture was allowed to stir for 1 h before the slow addition of pyrrolidine 
(130 μL, 112 mg, 1.57 mmol), which was subsequently allowed to warm to room 
temperature over 18 h. After this time the mixture was diluted with 50% ethyl acetate 
in hexanes and washed with water. The crude mixture was dried on Na2SO4, filtered 
and had the solvent removed under reduced pressure. The crude oil was purified by 
means of flash chromatography with 30% ethyl acetate: hexanes to afford 5f as a 
yellow oil in a 24% yield (18.3 mg, 0.06 mmol). IR (ATR): 3222, 2964, 2834, 1689, 
1600, 1578 cm-1. 1H NMR (400 MHz, CDCl3): δ 1.57 (s, 3H), 1.75-1.78 (m, 4H), 2.03 
(s, 3H), 2.42-2.47 (m, 2H), 2.69-2.74 (m, 2H), 3.82 (s, 3H), 6.54 (bs, 1H), 6.86-6.89 
(m, 1H), 7.01-7.03 (m, 2H), 7.32 (t, J = 8.4 Hz, 1H). 13CNMR (100 MHz, CDCl3): δ 
11.8, 23.9, 24.5, 46.7, 55.3, 77.7, 113.7, 114.9, 121.8, 129.3, 130.7, 132.7, 158.2, 




pyrrolidinyl)-1,2-ethanedione (6). To a solution of 3f (19.8 mg, 0.06 mmol) in DMF 
(1 mL, bench grade) under nitrogen was added pyrrolidine (50 μL, 43 mg, 0.6 mmol) 
followed by Cs2CO3 (45.0 mg, 0.14 mmol) at -78 
oC. The mixture was subsequently 
allowed to warm to room temperature over 18 h. After this time the mixture was 
diluted with 50% ethyl acetate in hexanes (5 mL) and washed with water (5 x 5 mL). 
The crude mixture was dried on Na2SO4, filtered and had the solvent removed under 
reduced pressure. The crude oil was purified by means of flash chromatography with 
30% ethyl acetate: hexanes to afford 6f as a yellow oil in 58% yield (10.8 mg, 0.03 
mmol). IR (ATR): 3297, 2969, 1687, 1623, 1428 cm-1. 1H NMR (400 MHz, CDCl3): 
δ 1.56 (s, 3H), 1.76 (dq, J = 10.8, 2.8 Hz, 2H), 1.83 (p, J = 6.6 Hz, 2H), 1.95 (p, J = 
6.6 Hz, 2H), 3.52 (t, J = 6.8 Hz, 2H), 4.00 (dt, J = 6.8, 3.6 Hz, 2H), 6.79-6.82 (m, 
1H), 7.07-7.12 (m, 3H), 7.25 (t, J = 8.0 Hz, 1H), 7.9 (bs, 1H). 13C NMR (100 MHz, 
CDCl3): δ 19.9, 21.5, 23.5, 26.9, 28.5, 48.0, 48.8, 55.3, 112.4, 113.3, 119.9, 120.4, 
129.6, 129.7, 138.6, 159.3, 159.9, 161.4. HRMS (+EI-Orbitrap): m/z For C18H22O3N2 




(7). Under an atmosphere of H2, 3f (88.9 mg, 0.26 mmol) was stirred in ethanol (10 
mL) for 2 days with Pd/C (8.0 mg) at room temperature. After this time the mixture 
was passed through a short plug of Celite® before the solvent was removed under 
reduced pressure to reveal a brown oil which was subsequently purified be means of 
flash chromatography with 30% ethyl acetate: hexanes to reveal 7 as a slightly yellow 
oil in a 41% yield (30.3 mg, 0.11 mmol). IR (ATR): 3292, 3096, 2959, 1663, 1489, 
1251 cm-1. 1H NMR (400 MHz, CDCl3): δ 0.57 (t, J = 6.0 Hz minor isomer), 0.68 (t, J 
= 6.0 Hz major isomer), 1.01 (dd, J = 9.0, 6.0 Hz, 1H, major isomer), 1.05 (dd, J = 
10.0, 6.0 Hz, 1H, minor isomer), 1.20-1.28 (m, 1H, major isomer), 1.28-1.34 (m, 1H, 
major isomer), 1.44 (s, 3H, major isomer), 1.49 (s, 3H, minor isomer), 2.51 (dd, J = 
15.0, 8.0 Hz, 1H, minor isomer), 2.62 (dd, J = 15.0, 8.0 Hz, 1H, major isomer), 2.83 
(dd, J = 15.0, 7.0 Hz, 1H, major isomer), 2.93 (dd, J = 15.0, 6.0 Hz, 1H, minor 
isomer), 3.83 (s, 3H, major isomer), 3.83 (s, 3H, minor isomer), 3.99 (s, 2H, minor 
isomer), 4.03 (s, 2H, major isomer), 6.78-6.90 (m, 3H, minor and major isomer), 7.25 
(t, J = 8.0 Hz, 1H, major isomer), 7.25 (t, J = 8.0 Hz, 1H, major isomer). 13C NMR 
(100 MHz, CDCl3): δ 18.3, 20.4, 20.6, 23.6, 25.4, 26.2, 33.3, 33.5, 35.0, 35.3, 42.8, 
42.9, 55.3, 55.3, 111.4, 111.5, 114.1, 114.3, 120.6, 120.8, 129.5, 129.7, 142.7, 142.9, 
159.8, 159.9, 166.0, 166.8. HRMS (+EI-Orbitrap): m/z For C14H18ClNO2 +Na calcd 
290.0923; found, 290.0918. 
 
General procedure for the synthesis of allenylcarbinols 10 
To a stirred solution of the appropriate cyclopropenylcarbinol 8 (1 equiv.) in CH2Cl2 
(~0.1 M), was added DBU (0.15 equiv.) followed by trichloroacetonitrile (1.5 equiv.) 
at -78 oC. The resulting solution was allowed to warm to -10 oC over a period of 2 h 
before the reaction mixture was evaporated to dryness under reduced pressure. The 
resulting oil was in most cases identified as the intermediate imidate by crude 1H 
NMR and was also used directly in the allene-formation step. The crude imidate (1 
equiv.) was dissolved in reagent-grade CH2Cl2 (~0.01 M), cooled to -10 
oC and silica 
gel (500 mg per 0.1 mmol of imidate) added. The reaction was stirred vigorously and 
allowed to warm to room temperature. After consumption of the starting material 
(typically about 3 h), the reaction was filtered, evaporated to dryness and purified by 




2,3-Dimethyl-5-phenylpenta-3,4-dien-2-ol (10a). From 8a as a pale yellow oil after 
filtration and evaporation to dryness and purification with 15% ethyl acetate: hexanes; 
14.1 mg, 48% yield. IR (ATR): 3593, 3054, 2986, 1421, 1265, 896, 733, 705 cm-1. 1H 
NMR (400 MHz, CDCl3) δ 1.45 (s, 6H), 1.90 (d, J = 2.9 Hz, 3H), 6.21 (q, J = 2.9 Hz, 
1H), 7.18-7.33 (m, 5H). 13C (100 MHz, CDCl3) δ 14.5, 29.0, 29.3, 71.7, 96.5, 111.9, 
126.6, 126.9, 128.7, 135.2, 200.6. HRMS (MMI-TOF): m/z For C13H16O -H calcd 
187.1201; found, 187. 187.1258. 
 
5-(2-Bromophenyl)-2,3-dimethylpenta-3,4-dien-2-ol (10b). From 8b as a pale orange 
viscous oil after purification with 15% ethyl acetate: hexanes; 22 mg, 61% yield over 
two steps. Imidate: 1H NMR (300 MHz, CDCl3): δ 1.22 (s, 3H), 1.29 (s, 3H), 2.16 (s, 
3H), 7.27 (3, 1H), 7.38 (t, J = 7.5 Hz, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.78 (d, J = 8.0, 
1.5 Hz, 1H), 7.81 (d, J = 8.0, 1.5 Hz, 1H), 8.67 (s, 1H). IR (ATR): 3313, 2977, 1953, 
1492, 1235 cm-1. 10b: 1H NMR (500 MHz, CDCl3): δ 1.41 (s, 6H), 1.88 (d, J = 2.0 
Hz, 3H), 6.62 (d, J = 2.0 Hz), 7.01 (t, J = 8.0 Hz, 1H), 7.21 (t, J = 7.5 Hz, 1H), 7.37 
(d, J = 8.0, 1.5 Hz, 1H), 7.50 (d, J = 8.0, 1.5 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 
14.6, 29.2, 29.3, 71.8, 95.5, 112.2, 122.6, 127.6, 128.3, 128.3, 133.3, 134.7, 201.9. 
HRMS (ASAP-TOF): m/z For C13H15BrO +H calcd 267.0385; found, 267.0378. 
 
5-(2-Fluorophenyl)-2,3-dimethylpenta-3,4-dien-2-ol (10c). From 8c as a clear oil after 
purification with 20% ethyl acetate: hexanes; 38.6 mg, 30% yield. IR (ATR): 3313, 
2977, 1953, 1492, 1235 cm-1. 1H NMR (500 MHz, CDCl3): δ 1.43 (s, 6H), 1.89 (d, J 
= 2.5 Hz), 6.40 (s, 1H), 7.01 (t, J  = 10 Hz, 1H), 7.07 (t, J = 7.0 Hz, 1H), 7.13-7.18 
(m, 1H), 7.31 (dt, J = 7.5, 1.5 Hz). 13C NMR (125 MHz, CDCl3): δ 14.4, 28.9, 29.0, 
71.5, 88.8, 111.5, 115.6 (d, J = 20.9 Hz), 122.7 (d, J = 11.5 Hz), 124.1, 128.0, 128.1, 
159.8 (d, J = 246.0 Hz), 201.5. HRMS (ASAP-TOF): m/z For C13H15FO +H – H2O 




NMR spectra for all new compounds. This material is available free of charge via the  
Internet at http://pubs.acs.org.  
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